Concepedia

Publication | Closed Access

Phase I and pharmacokinetic study of the new taxane analog BMS-184476 given weekly in patients with advanced malignancies.

28

Citations

8

References

2002

Year

Ruth Plummer, Michele Ghielmini, Paula Calvert, Maurizio Voi, J. Renard, Gilles Gallant, Elora Gupta, Hilary Calvert, Cristiana Sessa
PubMed

Abstract

The recommended dose and schedule of weekly BMS-184476 is 50 mg/m(2) on days 1 and 8 every 21 days.

References

YearCitations

Page 1